Patent intelligence · US
US 8821899
Method and process for the production of multi-coated recognitive and releasing systems
Method and process for the production of multi-coated recognitive and releasing systems
Patent details — US 8821899
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 2, 2014
- Expiration
- Aug 28, 2034
- Claims
- 8
- CPC classes
- A61K, A61K2800/413, A61K31/137, A61K38/28
Quick answer
US 8821899 (Method and process for the production of multi-coated recognitive and releasing systems) is held by The Board of Regents of the University of Texas System. Status: granted. Granted Sep 2, 2014. Expires Aug 28, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K2800/413, A61K31/137, A61K38/28, A61K47/34, A61K47/6903
More from The Board of Regents of the University of Texas System
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 8821899?
US 8821899 (Method and process for the production of multi-coated recognitive and releasing systems) is held by The Board of Regents of the University of Texas System. Status: granted. Granted Sep 2, 2014. Expires Aug 28, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8821899?
The Board of Regents of the University of Texas System is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 8821899 expire?
Our index shows an expiration date of Aug 28, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.